Modulation of the Basal Ganglia by Metabotropic Glutamate Receptors: Potential for Novel Therapeutics

E-ISSN： 2212-5299|1|3|239-250

ISSN： 1568-007X

Source： Current Drug Targets-CNS & Neurological Disorders, Vol.1, Iss.3, 2002-06, pp. : 239-250

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Novel Potential Therapeutics for Schizophrenia: Focus on the Modulation of Metabotropic Glutamate Receptor Function

Current Neuropharmacology, Vol. 3, Iss. 1, 2005-01 ,pp. : 9-34

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptor Ligands as Potential Therapeutics for Addiction

Current Drug Abuse Reviews, Vol. 2, Iss. 1, 2009-01 ,pp. : 83-98

Bentham Science Publishers

Access to resources Recommend Favorite

Therapeutic Potential of Group III Metabotropic Glutamate Receptors

Current Medicinal Chemistry, Vol. 15, Iss. 7, 2008-01 ,pp. : 671-684

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Targets for Novel Antipsychotic Treatments

Current Pharmaceutical Biotechnology, Vol. 13, Iss. 8, 2012-06 ,pp. : 1522-1534

Bentham Science Publishers

Access to resources Recommend Favorite

Metabotropic Glutamate Receptors as Targets for Analgesia: Antagonism, Activation, and Allosteric Modulation

Current Pharmaceutical Biotechnology, Vol. 12, Iss. 10, 2011-10 ,pp. : 1681-1688

Bentham Science Publishers

Access to resources Recommend Favorite